GILDER GAGNON HOWE & CO LLC – BioCryst Pharmaceuticals, Inc. Transaction History
GILDER GAGNON HOWE & CO LLC portfolio value:
$3.82M
portfolio value
GILDER GAGNON HOWE & CO LLC quarter portfolio value change:
+19.09%
quarter
BioCryst Pharmaceuticals, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -0.50% | -1.51K shares | 597K | $12.6 | 303.64K |
Q2 2022 | share | Decrease | -9.99% | -33.85K shares | -2.28M | $10.58 | 305.15K |
Q1 2022 | share | Decrease | -0.52% | -1.77K shares | 792K | $16.26 | 339.00K |
Q4 2021 | share | Increase | +8.60% | 26.97K shares | 211K | $13.79 | 340.77K |
Q3 2021 | share | Increase | +0.13% | 413 shares | -446K | $14.37 | 313.80K |
Q2 2021 | share | Increase | +48.24% | 101.98K shares | 2.80M | $15.81 | 313.39K |
Q1 2021 | share | Increase | 0.00% | 211.40K shares | 2.15M | $10.17 | 211.40K |
Q4 2020 | share | Decrease | -100.00% | -592.2K shares | -2.03M | $7.45 | 0 |
Q3 2020 | share | Increase | 0.00% | 592.2K shares | 2.03M | $3.44 | 592.2K |